Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Ryman Healthcare (RYM) vs. Competitors

1 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AU:RYMRyman HealthcareAUD 1.52AUD 1.58B-11.12-37.14%Moderate BuyUnlock the AU:RYM analyst price target with TipRanks PremiumAU:RYMUnlock the AU:RYM top-analyst price target with TipRanks Premium
NZ:OCAOceania HealthcareNZD 0.59NZD 449.02M-63.44-28.48%Moderate BuyUnlock the NZ:OCA analyst price target with TipRanks PremiumAU:RYM vs NZ:OCAUnlock the NZ:OCA top-analyst price target with TipRanks Premium
NZ:SUMSummerset Group Holdings LimitedNZD 5.79NZD 1.46B4.59-54.30%Strong BuyUnlock the NZ:SUM analyst price target with TipRanks PremiumAU:RYM vs NZ:SUMUnlock the NZ:SUM top-analyst price target with TipRanks Premium
NZ:PHLPromisia Healthcare LimitedNZD 0.62NZD 33.62M0.039.73%―Unlock the NZ:PHL analyst price target with TipRanks PremiumAU:RYM vs NZ:PHLUnlock the NZ:PHL top-analyst price target with TipRanks Premium
NZ:TAHThird Age Health Services LimitedNZD 3.86NZD 37.83M11.70-28.52%―Unlock the NZ:TAH analyst price target with TipRanks PremiumAU:RYM vs NZ:TAHUnlock the NZ:TAH top-analyst price target with TipRanks Premium
NZ:RADRadius Residential Care LtdNZD 0.40NZD 113.39M10.18-1.23%―Unlock the NZ:RAD analyst price target with TipRanks PremiumAU:RYM vs NZ:RADUnlock the NZ:RAD top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AU:RYMRyman Healthcare1.51-1.03-40.35%
NZ:OCAOceania Healthcare0.59-0.23-28.05%
NZ:SUMSummerset Group Holdings Limited5.79-6.54-53.05%
NZ:PHLPromisia Healthcare Limited0.620.0611.71%
NZ:TAHThird Age Health Services Limited3.86-1.55-28.66%
NZ:RADRadius Residential Care Ltd0.400.024.99%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts